Bodo Brocks

1.1k total citations
21 papers, 828 citations indexed

About

Bodo Brocks is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Bodo Brocks has authored 21 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Bodo Brocks's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Bodo Brocks is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Bodo Brocks collaborates with scholars based in Germany, United States and Switzerland. Bodo Brocks's co-authors include Dieter Moosmayer, Klaus Pfizenmaier, Ralf Ostendorp, Manuela Dürr, Stefan Steidl, Christian Frisch, Stefanie Urlinger, Yvonne Stark, Pilar Garin‐Chesa and Ingrid Pradel and has published in prestigious journals such as Journal of Molecular Biology, Applied and Environmental Microbiology and Hepatology.

In The Last Decade

Bodo Brocks

21 papers receiving 788 citations

Peers

Countries citing papers authored by Bodo Brocks

Since Specialization

Citations

This map shows the geographic impact of Bodo Brocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Brocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Brocks more than expected).

Fields of papers citing papers by Bodo Brocks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Brocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Brocks. The network helps show where Bodo Brocks may publish in the future.

Co-authorship network of co-authors of Bodo Brocks

This figure shows the co-authorship network connecting the top 25 collaborators of Bodo Brocks. A scholar is included among the top collaborators of Bodo Brocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodo Brocks. Bodo Brocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Solution Equilibrium Titration for High-Throughput Affinity Estimation of Unpurified Antibodies and Antibody Fragments 2015 ·SLAS DISCOVERY ·(unknown), Jan Jaehrling, (unknown), (unknown), (unknown), Ralf Ostendorp, Stefan Pabst, Bodo Brocks	9
2	Characterization and screening of IgG binding to the neonatal Fc receptor 2014 ·mAbs ·(unknown), (unknown), Jan Jaehrling, Sebastian Jäger, (unknown), Karin Felderer, (unknown), (unknown), (unknown), Johanna Kölln, Thomas Tiller, Bodo Brocks, Ralf Ostendorp, Stefan Pabst	78
3	An automated immunoassay for early specificity profiling of antibodies 2013 ·mAbs ·(unknown), (unknown), Ralf Ostendorp, Bodo Brocks, Stefan Pabst	10
4	In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification 2008 ·Molecular Immunology ·Stefan Steidl, (unknown), Bodo Brocks, Manuela Dürr, (unknown)	75
5	Fab MOR03268 Triggers Absorption Shift of a Diagnostic Dye via Packaging in a Solvent-shielded Fab Dimer Interface 2008 ·Journal of Molecular Biology ·R.C. Hillig, Stefanie Urlinger, Jörg Fanghänel, Bodo Brocks, (unknown), Yvonne Stark, Detlev Sülzle, Dmitri I. Svergun, (unknown), (unknown), Dieter Moosmayer, Andreas Menrad, Michael Schirner, Kai Licha	8
6	The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity Antibodies 2008 ·Journal of Molecular Biology ·Christine Rothe, Stefanie Urlinger, (unknown), Josef Prassler, Yvonne Stark, Ute Jäger, Bernd Hubner, (unknown), Ingrid Pradel, (unknown), (unknown), (unknown), Christian Frisch, Bodo Brocks, Annemarie Honegger, (unknown)	183
7	Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases 2007 ·Human Antibodies ·Bodo Brocks, (unknown), Stefan Zahn, (unknown), Clark Q. Pan, Michael Schauer, Barbara Krebs	10
8	Characterization of high-affinity antibodies by electrochemiluminescence-based equilibrium titration 2005 ·Analytical Biochemistry ·(unknown), (unknown), (unknown), Ralf Ostendorp, Bodo Brocks	21
9	Protein microarrays for antibody profiling: Specificity and affinity determination on a chip 2005 ·PROTEOMICS ·Oliver Poetz, Ralf Ostendorp, Bodo Brocks, Jochen M. Schwenk, Dieter Stoll, Thomas Joos, Markus F. Templin	63
10	Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats 2004 ·Hepatology ·Christopher J. Parsons, Blair U. Bradford, Clark Q. Pan, Ellen Cheung, Michael Schauer, (unknown), Barbara Krebs, (unknown), Stefan Zahn, Bodo Brocks, Nikki Feirt, Baisong Mei, (unknown), (unknown), (unknown), Paul K. Ng, (unknown), Claudia Hirth‐Dietrich, Adrian Tomkinson, David A. Brenner	155
11	From EST to IHC: human antibody pipeline for target research 2003 ·Journal of Immunological Methods ·Christian Frisch, Bodo Brocks, Ralf Ostendorp, Adolf Hoess, T von Rüden, Titus Kretzschmar	15
12	Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas 2001 ·International Journal of Cancer ·(unknown), Alexej Schmidt, Jörg F. Rippmann, (unknown), Bodo Brocks, Wolfgang J. Rettig, Pilar Garin‐Chesa, Klaus Pfizenmaier, Dieter Moosmayer	1
13	Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas 2001 ·International Journal of Cancer ·(unknown), Alexej Schmidt, (unknown), (unknown), Bodo Brocks, Wolfgang J. Rettig, Pilar Garin‐Chesa, Klaus Pfizenmaier, Dieter Moosmayer	39
14	Species-Crossreactive scFv Against the Tumor Stroma Marker “Fibroblast Activation Protein” Selected by Phage Display From an Immunized FAP−/− Knock-Out Mouse 2001 ·Molecular Medicine ·Bodo Brocks, Pilar Garin‐Chesa, (unknown), John E. Park, (unknown), Klaus Pfizenmaier, Dieter Moosmayer	52
15	Procaryotic Expression of Single-Chain Variable-Fragment (scFv) Antibodies: Secretion in L-Form Cells of Proteus mirabilis Leads to Active Product and Overcomes the Limitations of Periplasmic Expression in Escherichia coli 1998 ·Applied and Environmental Microbiology ·Jörg F. Rippmann, (unknown), Christian Hoischen, Bodo Brocks, Wolfgang J. Rettig, (unknown), Klaus Pfizenmaier, Ralf Mattes, Dieter Moosmayer	48
16	A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells 1997 ·Immunotechnology ·Bodo Brocks, (unknown), (unknown), Elke Gerlach, (unknown), Melvyn Little, Klaus Pfizenmaier, Dieter Moosmayer	22
17	Characterization of Different Soluble TNF Receptor (TNFR80) Derivatives: Positive Influence of the Intracellular Domain on Receptor/Ligand Interaction and TNF Neutralization Capacity 1996 ·Journal of Interferon & Cytokine Research ·Dieter Moosmayer, Harald Wajant, Elke Gerlach, M. Alexander Schmidt, Bodo Brocks, Klaus Pfizenmaier	17
18	A Bivalent Immunoadhesin of the Human Interferon-γ Receptor Is an Effective Inhibitor of IFN-γ Activity 1995 ·Journal of Interferon & Cytokine Research ·Dieter Moosmayer, Elke Gerlach, (unknown), (unknown), Bodo Brocks, Klaus Pfizenmaier	3
19	A single-chain TNF receptor antagonist is an effective inhibitor of TNF mediated cytotoxicity. 1995 ·PubMed ·Dieter Moosmayer, Stefan Dübel, Bodo Brocks, (unknown), (unknown), (unknown), Melvyn Little, Klaus Pfizenmaier	14
20	A Comparison of Flufenamic Acid and Phenylbutazone in Osteoarthritis of the Hip 1966 ·Lara D. Veeken ·Bodo Brocks	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact